1.38 -6.37 (-455.00%)
TARG
Stock Details
Last Trade:1.38 Change:-6.37 (-455.00%) Prev Close:7.75 Open: 1.40 Days Range:1.21 – 2.00 52 Week Range: 3.51 - 10.00 Volume:2865212 P/E: N/AEPS:-13.12
View AllRecent Alerts 11/20/08
Recent Alert on 11/20/08 at 12:30pm
Unusual 11 Mid-Day Movers 11/20: PERY, PALM, GYMB, NED Higher; TARG, PAY, EGLE, KWK Lower
Unusual 11 Mid-Day Movers 11/20: PERY, PALM, GYMB, NED Higher; TARG, PAY, EGLE, KWK Lower
Targanta Therapeutics Corp. (Nasdaq: TARG) 82.6% LOWER; the Advisory Committee voted by a narrow margin of 8-10 (against) that the data presented demonstrate the safety and effectiveness of oritavancin for the treatment of cSSSI. VeriFone... Read More
Recent Alert on 11/20/08 at 9:45am
Morning Movers 11/20: Suntech (STP) Sinks On Results/Guidance, Citi (C) Lower Despite Prince Alwaleed Backing
Morning Movers 11/20: Suntech (STP) Sinks On Results/Guidance, Citi (C) Lower Despite Prince Alwaleed Backing
Recent Alert on 11/20/08 at 9:34am
Targanta Therapeutics (TARG) Receives Mixed FDA Reviews of Investigational Antibiotic Therapy Treatment
Targanta Therapeutics (TARG) Receives Mixed FDA Reviews of Investigational Antibiotic Therapy Treatment
Recent Alert on 11/20/08 at 9:34am
Targanta Therapeutics (TARG) Receives Mixed FDA Reviews of Investigational Antibiotic Therapy Treatment
Targanta Therapeutics (TARG) Receives Mixed FDA Reviews of Investigational Antibiotic Therapy Treatment
View AllRecent Press Releases
Press Release on 11/19/08 at 9:17pm
FDA Advisory Committee Provides Opinion on Oritavancin for the Treatment of Complicated Skin and Skin Structure Infections
FDA Advisory Committee Provides Opinion on Oritavancin for the Treatment of Complicated Skin and Skin Structure Infections
Press Release on 11/17/08 at 12:29pm
Targanta Announces Posting of Briefing Documents for Review of FDA Anti-Infective Drugs Advisory Committee Meeting for Oritavancin
Targanta Announces Posting of Briefing Documents for Review of FDA Anti-Infective Drugs Advisory Committee Meeting for Oritavancin